← All Elite Pharmaceuticals INC /NV/ filings

Elite Pharmaceuticals INC /NV/ 8-K filings

OQB

14 Feb 2024

ELTP

8-K: Elite Pharmaceuticals Reports Strong Third Quarter Results with 68% Revenue Increase

Elite Pharmaceuticals announced a significant 68% increase in revenue and an 80% increase in operating profits for the third quarter of fiscal year 2024, driven by sales of its Elite Laboratories label products.